These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18774564)

  • 1. Thrombin-activatable fibrinolysis inhibitor polymorphisms and recurrent pregnancy loss.
    Masini S; Ticconi C; Gravina P; Tomassini M; Pietropolli A; Forte V; Federici G; Piccione E; Bernardini S
    Fertil Steril; 2009 Aug; 92(2):694-702. PubMed ID: 18774564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
    Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
    Orikaza CM; Morelli VM; Matos MF; Lourenço DM
    Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
    Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women.
    Saijo Y; Sata F; Yamada H; Kondo T; Kato EH; Kishi R
    Fertil Steril; 2004 Feb; 81(2):374-8. PubMed ID: 14967376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
    Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
    Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.
    Acosta-Tejeda M; Baptista-González H; Rosenfeld-Mann F; Trueba-Gómez R; García-Latorre E
    Thromb Res; 2011 Oct; 128(4):e39-42. PubMed ID: 21708401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the protein Z intron F G79A gene polymorphism with recurrent pregnancy loss.
    Dossenbach-Glaninger A; van Trotsenburg M; Helmer H; Oberkanins C; Hopmeier P
    Fertil Steril; 2008 Oct; 90(4):1155-60. PubMed ID: 18177644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss.
    Papazoglou D; Galazios G; Papatheodorou K; Liberis V; Papanas N; Maltezos E; Maroulis GB
    Fertil Steril; 2005 Apr; 83(4):959-63. PubMed ID: 15820807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of early recurrent fetal loss and levels of thrombin-activatable fibrinolysis inhibitor.
    Legnani C; Bovara M; Valdrè L; Cosmi B; Caniato A; Palareti G
    Thromb Res; 2012 Aug; 130(2):237-41. PubMed ID: 22032800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
    Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
    Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women.
    Kamali-Sarvestani E; Zolghadri J; Gharesi-Fard B; Sarvari J
    J Reprod Immunol; 2005 Apr; 65(2):171-8. PubMed ID: 15811521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion.
    Lee HH; Hong SH; Shin SJ; Ko JJ; Oh D; Kim NK
    Fertil Steril; 2010 Mar; 93(4):1244-7. PubMed ID: 19131057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.
    Firouzabadi RD; Ghasemi N; Rozbahani MA; Tabibnejad N
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):216-9. PubMed ID: 19432615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss.
    Eller AG; Branch DW; Nelson L; Porter TF; Silver RM
    J Reprod Immunol; 2011 Jan; 88(1):48-52. PubMed ID: 20977975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of consistent association between endothelial nitric oxide synthase gene polymorphisms, homocysteine levels and recurrent pregnancy loss in tunisian women.
    Zammiti W; Mtiraoui N; Mahjoub T
    Am J Reprod Immunol; 2008 Feb; 59(2):139-45. PubMed ID: 18211539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFA gene promoter polymorphisms and susceptibility to recurrent pregnancy loss in Italian women.
    Palmirotta R; La Farina F; Ferroni P; Ludovici G; Nigro C; Savonarola A; Raparelli V; Riondino S; Rampini MR; Guadagni F; Basili S
    Reprod Sci; 2010 Jul; 17(7):659-66. PubMed ID: 20388617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.
    Vairaktaris E; Yapijakis C; Nkenke E; Vassiliou S; Vylliotis A; Nixon AM; Derka S; Ragos V; Spyridonidou S; Tsigris C; Neukam FW; Patsouris E
    Am J Hematol; 2007 Nov; 82(11):1010-2. PubMed ID: 17636471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.